Corvus Pharmaceuticals Inc (CRVS)
9.07
+0.13
(+1.45%)
USD |
NASDAQ |
Nov 22, 12:52
Corvus Pharmaceuticals Shareholders Equity (Quarterly): 12.41M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 12.41M |
| June 30, 2024 | 51.23M |
| March 31, 2024 | 33.36M |
| December 31, 2023 | 38.68M |
| September 30, 2023 | 44.29M |
| June 30, 2023 | 49.48M |
| March 31, 2023 | 48.87M |
| December 31, 2022 | 56.12M |
| September 30, 2022 | 64.68M |
| June 30, 2022 | 80.39M |
| March 31, 2022 | 89.72M |
| December 31, 2021 | 97.16M |
| September 30, 2021 | 105.15M |
| June 30, 2021 | 96.40M |
| March 31, 2021 | 94.38M |
| December 31, 2020 | 72.15M |
| September 30, 2020 | 42.35M |
| June 30, 2020 | 50.84M |
| March 31, 2020 | 60.04M |
| Date | Value |
|---|---|
| December 31, 2019 | 71.11M |
| September 30, 2019 | 80.41M |
| June 30, 2019 | 89.65M |
| March 31, 2019 | 100.70M |
| December 31, 2018 | 110.34M |
| September 30, 2018 | 118.85M |
| June 30, 2018 | 127.40M |
| March 31, 2018 | 137.23M |
| December 31, 2017 | 84.84M |
| September 30, 2017 | 93.74M |
| June 30, 2017 | 104.78M |
| March 31, 2017 | 118.22M |
| December 31, 2016 | 132.80M |
| September 30, 2016 | 142.91M |
| June 30, 2016 | 151.97M |
| March 31, 2016 | 152.55M |
| December 31, 2015 | -31.10M |
| September 30, 2015 | -25.31M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
12.41M
Minimum
Sep 2024
105.15M
Maximum
Sep 2021
62.94M
Average
58.08M
Median
Shareholders Equity (Quarterly) Benchmarks
| Azenta Inc | 1.769B |
| Perspective Therapeutics Inc | 328.47M |
| Atara Biotherapeutics Inc | -90.54M |
| Clearside Biomedical Inc | -34.79M |
| Quanterix Corp | 336.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.82M |
| Total Liabilities (Quarterly) | 46.41M |